$263K spent in the last 30 days across 8 active campaigns. The structure is good — the constraints are measurement, ad policy, and a brand program that's far smaller than it should be. All revenue and order figures on this page come from Triple Whale unless labeled otherwise.
The naming convention is consistent: campaigns with ONB ("own brand") in the
name are Brand; campaigns with COMP (competitor/category) are Non-Brand.
The NAD campaign is a non-brand product line.
| Campaign (active) | Segment | Bidding | Spend 14d | Triple Whale rev | Orders | ROAS | CPA |
|---|---|---|---|---|---|---|---|
| LD_GLP_COMP_US_Search_tCPA(Portfolio) | Non-Brand | Portfolio Target CPA $60 | $128,067 | $373,744 | 4,067 | 2.92 | $31.49 |
| LD_GLP_ONB_US_mCPC | Brand | Manual CPC | $2,641 | $56,715 | 680 | 21.48 | $3.88 |
| LD_GLP_ONB_US_Search_REVIEW | Brand | Max Conversions (no target) | $2,598 | $2,511 | 25 | 0.97 | $103.91 |
| LD_GLP_COMP_CAN_Search_tCPA_38 | Non-Brand | Target CPA $38 | $158 | $1,377 | 25 | 8.72 | $6.32 |
| LD_GLP_COMP_AUS_Search_tCPA_38 | Non-Brand | Target CPA $38 | $106 | $657 | 11 | 6.20 | $9.64 |
| LD_NAD_COMP_US_Search_tCPA_26 | Non-Brand | Target CPA $26 | $14 | $386 | 8 | 28.15 | $1.71 |
| LD_GLP_ONB_INT_mCPC (international) | Brand | Manual CPC | <$100 | — | — | — | — |
| LD_GLP_ONB_US_mCPC Max Converisons | Brand | Dormant duplicate — recommend removing from active set | ~$0 | — | — | — | — |
Window May 28 – Jun 10 · Triple Whale last-click (each order credited to the last ad clicked). Spend from Google Ads (the only correct source for cost). The PMax brand/generic campaigns live in the other account — see PMax & Shopping.
Brand returns $21 per dollar on Search (Triple Whale) and still loses 26% of its impressions. Non-brand returns $2.92 per dollar at a $31.49 CPA — well inside the $60 target the bidding engine believes it's missing. Both segments are underfed for the same root cause: Google's own conversion tag only sees ~42% of these orders, so Smart Bidding thinks performance is twice as expensive as it really is.
The $20K/day shared budget never caps. The throttle is the $60 target CPA fed by under-counted conversions. Brand sits at 73.9% impression share (26.1% lost to rank); the US non-brand campaign at ~36% (64.1% lost to rank). The fix sequence: repair tracking → recalibrate targets → watch impression share unlock at the same true CPA.
All counts below cover active ads in active ad groups and campaigns only (98 ads).
21 limited for Clickbait (including the $58.5K/90d Berberine ad) and 2 disapproved with Destination Mismatch + Restricted Drug Terms + Prescription Drug Sale flags. Flagged ads carried $117.7K of the last 90 days' spend. In this category — where regulators are already active — this is the account's largest risk.
Concentrated in the highest-volume competitor ad groups (Kind GLP-1 Patches: $62K+). Rebuilding these responsive search ads is the cheapest attack on the 64% rank-lost impression share — better ads raise Ad Rank without raising bids.
Active ads claim "Summer Sale – Save 30%", "50% off Now", and "Save 50% – trusted by over 130,000 women" at the same time. Pick the live offer, align every ad — inconsistent discounts also feed the Clickbait policy flag. Bonus gap: zero promotion extensions account-wide despite running sale copy.
56 keywords + 55 search terms spent >$50 each with zero conversions: informational queries ("berberine benefits" $170), marketplace intent ("glp 1 patches amazon"), typo traffic ("glo1 patches"). Straightforward negative-keyword work.
Final URLs extracted from all active ads. Two domains do all the work — neither is ledisa.com.
| Campaign | Landing page | Ad groups | Message match |
|---|---|---|---|
| COMP US (non-brand) | myhealthyshape.com/v1g-top5-glp-1-patches | 16 | Strong — "Top 5" advertorial matches comparison intent |
| COMP US (berberine ad groups) | myhealthyshape.com/V1f-top5-berberine-patches | 3 | Strong — ingredient-matched variant |
| COMP CAN / COMP AUS | myhealthyshape.com/top5-glp-1-patches | 14+14 | Strong (same advertorial, intl variant) |
| NAD US | myhealthyshape.com/nad-patches/top-5-ranked | 2 | Strong |
| ONB REVIEW (brand) | myhealthyshape.com/ (homepage) | 1 | Mismatch — people searching "ledisa reviews / is ledisa legit" land on a generic advertorial homepage. See the Reviews proposal below. |
| ONB mCPC (brand) | tryledisa.com/pages/sp-gm3-glp-patches | 1 | OK — brand sales page, but on a third domain (tryledisa.com, not ledisa.com), which adds a hop where tracking can break |
| ONB INT (brand intl) | tryledisa.com/products/glp-1-patches-4 | 1 | OK — product page (this campaign holds the 2 disapproved ads) |
The current funnel: ad → myhealthyshape.com "Top 5 GLP-1 Patches" listicle (Ledisa ranked #1 with an A+ grade and 9.7/10 score, letter-graded competitors, 50%-off CTAs, urgency banners, affiliate-style disclaimer) → tryledisa.com checkout. The format works — comparison-shaped persuasion for comparison-shaped searches — but it's a single point of failure, it leans on Clickbait-flagged headline styles, and one page cannot match every search intent the account buys.
We ran fresh keyword research (Google Keyword Planner, US, June 2026) to back three new advertorial pages — same visual system as the current one, different angles and intents:
The berberine universe is much bigger and ~3× cheaper per click than the GLP-1 patch universe — and it's where Kind, Gentle and Patched have already moved their naming. The current V1f variant covers 3 ad groups; this deserves a full campaign of its own.
| Keyword | Searches/mo | Bid range |
|---|---|---|
| berberine | 450,000 | $0.62–1.94 |
| berberine supplement | 74,000 | $0.75–2.50 |
| berberine for weight loss | 40,500 | $0.67–3.11 |
| best berberine supplement | 12,100 | $1.11–3.50 |
| Reference: glp 1 patches | 165,000 | $2.10–8.72 |
"Patch vs pill" — why transdermal berberine beats swallowing capsules (no digestion loss, steady release). Comparison table includes capsule brands, not just patches — a bigger, less contested frame.
Story-led editorial (not a listicle): cortisol, perimenopause and hormonal weight gain. Low competition, very cheap clicks, perfectly matched to the core buyer (women 35–60), and naturally compliant — the story is about the problem, the patch enters as one part of a routine.
| Keyword | Searches/mo | Competition | Bid range |
|---|---|---|---|
| menopause weight gain | 5,400 | High | $0.29–6.99 |
| perimenopause weight gain | 5,400 | High | $0.32–7.80 |
| cortisol and belly fat / weight gain | 5,800 comb. | Low–Medium | $0.05–2.21 |
| hormonal weight gain | 3,800 comb. | Medium | $0.19–8.07 |
| weight loss for women over 40 | 2,600 comb. | High | $3.27–17.21 |
Educational explainer on appetite signals and craving control with structure/function language only — captures the huge appetite-suppressant cluster while staying far from drug claims (important: never use "suppressant" in ad copy — the advertorial frames it as "appetite support").
| Keyword | Searches/mo | Bid range |
|---|---|---|
| appetite / hunger suppressant | 148,000 comb. | $2.04–16.38 |
| natural appetite suppressant | 54,200 comb. | $0.29–9.52 |
| how to stop cravings (long-tail cluster) | ~8,000 | $0.30–4.00 |
Build plan for all three: reuse the current advertorial's design system (white editorial layout, rating cards, pros/cons, guarantee block) with compliant claim language; each page gets its own campaign so search intent, message and economics stay separated. Pages to be designed and presented for approval before publishing.
Today the Search account is ~100% GLP-1. But Ledisa sells a full wellness range, and Keyword Planner shows several of these lines have large, cheaper, lower-competition demand than the saturated weight-loss space. Below is a campaign structure for the rest of the catalog, with the landing chosen by search intent: category/commercial queries go to the existing store product pages; problem-aware/educational queries go to advertorials (to be designed, you choose which to build).








Volumes & bid ranges: Google Keyword Planner, US, June 2026. Intent column drives the landing choice.
| Product line | Anchor keywords (volume/mo) | Intent | Recommended landing | Tier |
|---|---|---|---|---|
| NAD+ / Longevity | nad supplement (110K), nmn supplement (110K), nad+ supplement (49.5K), nicotinamide riboside (40.5K) | Commercial / category | Store PDP — /nad-patches (buyers know the category) + optional "patch vs pill/IV" advertorial | 1 — build first |
| Dopamine / Focus | nootropics (74K), brain fog (60.5K, low comp), dopamine patch (33.1K, low comp), nootropic supplement (22.2K) | Mixed — "dopamine patch" commercial, "brain fog" problem-aware | Both — /dopamine-patches for category terms + a "beat brain fog" advertorial for problem terms | 1 — build first |
| Unpuff / De-bloat | bloating relief (22–49K, low comp), how to debloat (22K), debloat (14.8K), lose water weight (14.8K) | Problem-aware / educational | Advertorial — "how to beat the bloat" + /unpuff-patches for "debloat patch" | 1 — build first |
| Relax / Cortisol | supplements to reduce cortisol (40.5K), cortisol supplement (22.2K), stress relief supplement (14.8K) | Problem-aware | Advertorial (shares the "cortisol" angle with over-40 advertorial #3) + /relax | 2 — test |
| Sleep | natural sleep aid (27.1K), sleep patch / herbal sleep aid (27.1K). Avoid commodity heads (melatonin 368K, magnesium-for-sleep 110K — cheap CPC but brutal competition) | Category, narrow | Store PDP — /sleep-patches; bid only the patch/natural-aid terms, not the ingredient heads | 2 — test |
| Energy / B12 | vitamins for energy (14.8K), b12 benefits (18–27K, low comp, informational), b12 patch | Mostly informational | Store PDP — /energy-patches for "b12 patch / energy patch" only | 3 — low priority |
| Focus · Recovery · Metabolism · Glow Up | thinner Search demand in this set | Mixed | Better served by Shopping / PMax than dedicated Search — see PMax page | 3 — low priority |
LD_NAD_COMP_US_Search, LD_DOPA_COMP_US_Search,
LD_BLOAT_COMP_US_Search, etc. (the existing LD_NAD_COMP_US is the template — it
already returns 28× on Triple Whale at tiny spend, proof the model travels).[dopamine patch]; discovery terms in
phrase "natural sleep aid" in a small mining ad group that graduates
winners to exact (same mining logic as the brand build below).Commercial / category queries ("nad+ supplement", "dopamine patch", "natural sleep aid") → existing store product page — the visitor already knows the category and wants to buy. Problem-aware / educational queries ("brain fog", "how to debloat", "supplements to reduce cortisol") → advertorial — the visitor needs the problem framed before the product. You tell us which advertorials to build; the store PDPs already exist and can go live immediately.
Where this data comes from: Ledisa's account has dedicated competitor ad groups (one per competitor brand) plus competitor-brand keywords. The table below is at ad-group level: spend from Google Ads, revenue and orders from Triple Whale (which records the ad group of the last clicked ad on every order — Triple Whale sees ad-group level, not keyword level). Last 14 days.
| Competitor ad group | Spend 14d | Triple Whale rev | ROAS | CPA | Field check (see Competitors) |
|---|---|---|---|---|---|
| Patched GLP-1 Patches | $10,689 | $24,784 | 2.32 | $41.59 | Brand is fading (sold out, repositioning) — economics fine today, watch volume decay |
| Kind GLP-1 Patches | $9,025 | $30,347 | 3.36 | $25.35 | Category leader — keep, rebuild its POOR ads |
| Slimming Patches | $6,711 | $11,328 | 1.69 | $53.69 | Weakest large line — trim or re-angle |
| Gentle GLP-1 Patches | $3,415 | $7,271 | 2.13 | $41.64 | Direct playbook peer |
| Moringa Patches | $2,552 | $8,580 | 3.36 | $34.49 | Healthy |
| Purisaki | $1,995 | $3,323 | 1.67 | $53.93 | Clone-funnel operator — capture its doubt searches instead |
| Lean Patch | $1,267 | $2,709 | 2.14 | $43.68 | Same operator as Ozempatch |
| Nano Microneedling Patch | $975 | $1,895 | 1.94 | $54.17 | Semaglutide-adjacent — policy risk outweighs return |
| TonePatch GLP-1 Patches | $804 | $1,894 | 2.36 | $38.29 | Fine at this size |
| Ozempatch | $652 | $3,217 | 4.94 | $14.81 | Best conquest ROAS — but the keyword set carries drug-term policy risk; harvest carefully |
| Lipovia | $452 | $1,352 | 2.99 | $32.26 | Unstable operator — doubt-moment capture opportunity |
Earlier platform-only analysis suggested Patched was wasteful; the Triple Whale cross-check shows it converting at 2.32 — the field risk is future volume, not current efficiency. This is exactly why every performance read in this audit uses Triple Whale.
Brand currently returns $21 per dollar and loses a quarter of its impressions. The proposal:
split one catch-all campaign into five intent-matched campaigns, each with its own job, and let an
automated rule maintain bids. Reminder on syntax used below: exact match is written
[keyword], phrase match is written "keyword".
| Campaign | Match type | What goes in it | Bidding |
|---|---|---|---|
| 1 · Brand Core | [exact] | [ledisa], [ledisa patches], [ledisa glp-1 patches] — the pure brand terms | Manual CPC + the IS rule below |
| 2 · Brand Products | [exact] | Brand + product line: [ledisa nad patch], [ledisa sleep patch], [ledisa berberine], [ledisa dopamine patch], [ledisa energy patch] — protects every SKU's branded demand as the catalog expands | Manual CPC + the IS rule below |
| 3 · Brand Modifiers | [exact] | Misspellings ([leidsa], [ladisa], [ledissa], [ledisa patch]) and domain / .com variants ([ledisa.com], [ledisa com], [www ledisa], [tryledisa]) | Manual CPC + the IS rule below |
| 4 · Brand Reviews | [exact] + "phrase" | [ledisa reviews], [is ledisa legit], "does ledisa work", "ledisa side effects" → lands on a dedicated Reviews page (below) | Bidding test: Max Conversions vs Manual CPC |
| 5 · Brand Mining | "phrase" + broad | Broad/phrase brand terms whose only job is discovering new brand query variants. Weekly: converting search terms graduate to [exact] in campaigns 1–3; everything mined is negated here to prevent overlap | Max Conversions, low budget |
The exact-match brand campaigns (1, 2, 3) run a daily automated rule keyed to yesterday's impression share:
IF impression share < 90% → raise bids +$0.05 IF impression share ≥ 90% → lower bids −$0.07
This is not a one-time bid set — it's a self-correcting control loop. Because the decrease (−$0.07) is larger than the increase (+$0.05), the rule is permanently biased toward probing downward: every day it's holding ≥90% share, it shaves the bid to test whether it can hold that share for less. The moment share slips below 90%, it climbs back just enough to recover it. Over time the bid converges to the lowest CPC that still wins ~90% of brand impressions — and it keeps re-converging on its own as competitors enter or leave the brand auction. The result is the ideal brand-defense state: maximum impression share at minimum cost-per-click, with zero manual maintenance. On a campaign already returning $21 per dollar, every cent shaved off CPC is pure margin.
A dedicated reviews destination with real aggregated ratings, verified-buyer testimonials, third-party review links, transparent guarantee terms and an FAQ answering "is it legit / does it work / side effects" head-on. Message-matched to the doubt moment — and the trust asset the whole category lacks (see Competitors: every rival fakes scarcity; nobody owns credible proof). Built on Ledisa's visual system; replaces the current mismatched advertorial-homepage destination for the REVIEW campaign (which runs at a $103.91 CPA today).